Rep. Tim Kennedy, D-N.Y., has secured $338,000 in federal funding to expand drug compounding capacity in Western New York.
The investment will support development of a secure, regulated space at Buffalo, N.Y.-based D’Youville University’s School of Pharmacy for sterile and nonsterile compounding, aimed at addressing ongoing drug shortages and improving access to treatments such as cancer therapies, according to a May 1 news release.
The expansion also seeks to close regional access gaps and support research and workforce development tied to pharmacy services in the region. The nearest provider offering sterile, nonsterile and hazardous compounding services is about 15 miles away, creating barriers for patients requiring complex therapies.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
